ISRCTN15704862已完成未知
Testing Radical prostatectomy in men with prostate cancer and oligoMetastases to the bone (TRoMbone): a randomised controlled feasibility trial
niversity of Oxford (UK)0 个研究点目标入组 50 人开始时间: 2016年2月5日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- Male
入选标准
- •Men under 75 years old with locally resectable, oligometastatic prostate cancer, and fit for radical prostatectomy
排除标准
- •Current exclusion criteria as of 18/10/2017:
- •1. Contraindications to radical prostatectomy
- •2. Visceral metastases
- •3. Prior radiotherapy to the abdomen/pelvis or to skeletal metastases
- •4. Any systemic therapy of prostate cancer (including standard care) for 12 or more months
- •5. Participation in another prostate cancer clinical trial
- •Previous exclusion criteria:
- •1. Contraindications to radical prostatectomy
- •2. Visceral metastases
- •3. Prior radiotherapy to the abdomen/pelvis or to skeletal metastases
- •4. Any systemic therapy of prostate cancer (including treatment-as-usual) for 3 or more months
- •5. Participation in another prostate cancer clinical trial
研究者
相似试验
招募中
不适用
How common is bacteria in the urine of patients with urinary catheters after radical surgery on the prostate for prostate cancer and does it get cleared one week after removing the catheterACTRN12610000966099Mr Robert Davies100
进行中（未招募）
1 期
A Phase 1/2, Open-Label Study in Men with Prostate Cancer to Assess the Safety, Pharmacokinetics, and Testosterone-Lowering Efficacy of TAK-448, Administered as a 1 Month Depot, Including a Randomized Portion With a Group Administered LeuproreliMedDRA version: 12.1Level: LLTClassification code 10007113Term: Cancer of prostateProstate cancerEUCTR2009-017668-18-FRMillennium Pharmaceuticals, Inc.
进行中（未招募）
不适用
Testing of a new drug in men with prostate cancer that may help lower testosterone levels.Prostate cancerEUCTR2009-017668-18-BEMillennium Pharmaceuticals, Inc.123
进行中（未招募）
不适用
Partial prostate Ablation versus Radical Treatment (PART): Comparing partial ablation of the prostate to treatment or removal of the whole prostate in men with localised cancer of one side of the prostate onlyCancerProstate cancerISRCTN17249875niversity of Oxford800
进行中（未招募）
不适用
A Clinical Phase II Study in Patients with Prostate Cancer and Bone Metastases with KML001 (KOMINOX®) - KML001 in patients with prostate cancer and bone metastasesProstate Cancer MetastaticMedDRA version: 8.1Level: LLTClassification code 10036909Term: Prostate cancer metastaticEUCTR2006-005607-33-DEKOMINOX USA, Inc.